Evidence map›Paper›PMID 39541273›Full record

ArticlePloS one2024

Development of a lambda Red based system for gene deletion in Chlamydia.

Yibing Wang, Robert Suchland, Amy Hua, Steven Carrell, Daniel Rockey, Kevin Hybiske

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Complete deletion of theInfection and immunity · 2025
    Article
  6. Journal of bacteriology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yibing WangDepartment of Medicine, University of Washington, Seattle, Washington, United States of America.
Robert SuchlandDepartment of Medicine, University of Washington, Seattle, Washington, United States of America.
Amy HuaDepartment of Biomedical Sciences, Oregon State University, Corvallis, Oregon, United States of America.
Steven CarrellDepartment of Biomedical Sciences, Oregon State University, Corvallis, Oregon, United States of America.
Daniel RockeyDepartment of Biomedical Sciences, Oregon State University, Corvallis, Oregon, United States of America.
Kevin HybiskeDepartment of Medicine, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0002-2967-3079

Funding

Functional genomics for ChlamydiaR01AI126785 · NIAID · UNIVERSITY OF WASHINGTON · PI HEFTY, P SCOTT, HYBISKE, KEVIN · 2016 to 2025
$7.1M
NIAID NIH HHS R01 AI126785
6 · The paper itself

Abstract

The ability to efficiently target loci in the Chlamydia trachomatis genome for deletion remains a desirable goal in the field and new strategies need to be developed and refined. Here we describe the development and application of a lambda red recombineering system for Chlamydia. Using a non-replicative plasmid encoding key lambda Red components and targeting sequences, we demonstrate the efficient deletion of numerous gene targets in the model chlamydial strains C. trachomatis L2/434 and C. muridarum. For initial development of the system, we targeted the incA gene of C. trachomatis for deletion. Deletion mutants containing a chloramphenicol resistance marker were recovered within 3 rounds of selection, or 2 rounds of passaging, in McCoy cells and the resulting clones (CTΔincA) were verified by PCR-based genotyping and whole genome sequencing. Phenotypic assessment of host cells infected with CTΔincA was performed by immunofluorescence microscopy and confirmed the lack of IncA expression and the uniform presence of nonfusogenic vacuoles (inclusions) across CTΔincA-infected monolayers. To explore the utility of this system, we deleted 5 additional candidate virulence factors in C. trachomatis and C. muridarum, including deletions of single and multiple genes. We expect lambda Red recombineering to offer a powerful new strategy for making gene deletion and/or replacement mutants in Chlamydia.

Indexed as

Bacteriophage lambdaChlamydia trachomatisGene DeletionChlamydia InfectionsChlamydia muridarumHumansPlasmids

Identifiers

PMID39541273
PMCPMC11563418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.